Navigation Links
Isis Pharmaceuticals to Present at the Stifel Nicolaus Healthcare Conference 2011
Date:9/1/2011

CARLSBAD, Calif., Sept. 1, 2011 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (Nasdaq: ISIS), the leader in antisense therapeutics, today announced that management will present a company overview at Stifel Nicolaus' Healthcare Conference 2011 on Thursday, September 08, 2011 at 2:05 p.m. ET at the Four Seasons Hotel in Boston.

A live audio webcast of the presentation will be available on the "Investors & Media" section of the Company's Web site, www.isispharm.com.  A replay of the presentation will be available on the Isis Web site within 48 hours and will be archived for a limited time.

ABOUT ISIS PHARMACEUTICALS, INC.

Isis is exploiting its leadership position in antisense technology to discover and develop novel drugs for its product pipeline and for its partners.  Isis' broad pipeline consists of 24 drugs to treat a wide variety of diseases with an emphasis on cardiovascular, metabolic and severe and rare/neurodegenerative diseases, and cancer.  Isis' partner, Genzyme, plans to commercialize Isis' lead product, mipomersen following regulatory approval, which is expected in 2012.  Isis' patents provide strong and extensive protection for its drugs and technology.  Additional information about Isis is available at www.isispharm.com.


'/>"/>
SOURCE Isis Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Optimer Pharmaceuticals to Present at September 2011 Investor Conferences
2. Optimer Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
3. UPDATING and ADDING: Questcor Pharmaceuticals to Present at Upcoming Investor Conferences in September
4. Vanda Pharmaceuticals to Participate in Stifel Nicolaus Global Healthcare Conference and Jefferies Fall 2011 Mid-Atlantic Corporate Access Day
5. Auxilium Pharmaceuticals, Inc. and BioSpecifics Technologies Corp. Announce Plans to Develop Additional Indications using XIAFLEX®
6. Onyx Pharmaceuticals Appoints Dr. Helen Torley as Chief Commercial Officer
7. Cadence Pharmaceuticals to Present at Three Investment Conferences During the Month of September 2011
8. Avanir Pharmaceuticals to Present at Stifel Nicolaus Healthcare Conference
9. Cumberland Pharmaceuticals to Present at the UBS Global Life Sciences Conference In New York
10. Syndax Pharmaceuticals to Present at Upcoming Fall Financial Conferences
11. Auxilium Pharmaceuticals Announces Investor Event to Occur at 2011 ASSH Meeting on September 9, 2011
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... MATEO, Calif. , March 27, 2017 /PRNewswire/ ... been acquired by Ethicon, a division of Johnson ... Management System for the treatment of gastro-esophageal reflux ... magnetic sphincter augmentation (MSA) technology and the procedure ... medical centers. Torax Medical was founded ...
(Date:3/27/2017)... FinancialBuzz.com News Commentary  ... to a new report by Arcview Market Research, the legal cannabis consumer ... $6.7 billion and can be expected to grow at a 27 percent ... $6.7 billion in 2016, to $22.6 billion in 2021. This more than ... without a doctor,s recommendation. Voters in California , ...
(Date:3/27/2017)... 2017 The staggering cost of cancer treatment ... access to the latest treatment options against cancer. Even ... patients have inadequate or no health insurance and are ... Access to modern cancer treatment is almost non-existent for ... The mission statements of pharmaceutical and biotech companies ...
Breaking Medicine Technology:
(Date:3/28/2017)... WASHINGTON, DC (PRWEB) , ... March 28, 2017 , ... ... and Dr. Toni Bark , WHAT: , Medical doctors and PhD scientists will speak ... have written to President Trump in support of an independent vaccine safety commission. ...
(Date:3/28/2017)... (PRWEB) , ... March 28, 2017 , ... The ... MHA, FRBMA, has begun to serve as its new executive director. Mr. Still was ... Executive Search Committee. , “Bob, as he is known to our members, has ...
(Date:3/28/2017)... Calif. (PRWEB) , ... March 28, 2017 , ... ... its leading physicians, Paul Yost, will begin serving as new board chair for ... this month. Yost will serve the remainder of soon-to-be former chair Mark Refowitz’s ...
(Date:3/28/2017)... ... March 28, 2017 , ... Neurotechnology ... two biometric time and attendance tracking products: the new NCheck Cloud Bio Attendance ... Bio Attendance uses biometric face recognition to enable users to check in and ...
(Date:3/28/2017)... ... March 28, 2017 , ... METTLER TOLEDO Process Analytics ... power plant water and steam. , Chlorides and sulfates cause pitting and stress ... extensive maintenance and unplanned shutdowns. Monitoring these ions at low ppb levels has ...
Breaking Medicine News(10 mins):